Research Areas

An Open-Label, Randomized, Multicenter, Phase III Study to Compare the Immunogenicity, Efficacy and Safety of A Biosimilar Insulin Glargine Injection to Lantus (Insulin Glargine Injection) in Adult Subjects with Type I Diabetes Mellitus

A Randomized, Double Blind, Placebo Controlled, Parallel Group Study Assessing the Effect of An Investigational Device on Body Weight in Overweight and Obese Subjects with Prediabetes and Metformin-Treated Type 2 Diabetes

A Randomized, Double Blind, Dose Finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of An Investigational Medication Compared to Placebo in Obese or Overweight Adults Followed by 24 Weeks Treatment With 2 Doses of An Investigational Medication and Placebo

Dosing Flexibility Study of An Investigational Oral Testosterone in Hypogonadal Men

A 12-Month, Randomized, Active Controlled, Open Label Study of the Efficacy and Safety of An Investigational Oral Testosterone in Hypogonadal Men

A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial With An Open-Label Extension Phase of An Investigational Medication as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated with Lennox-Gastaut Syndrome

A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Determine Whether, In Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, An Investigational Medication on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality

An Evaluation of Six-Day Subcutaneous Glucose Sensor Performance in Subjects with Type 1 Diabetes Mellitus (P)

A Randomized, Parallel Study to Compare Performance of the Human Serum Albumin Sensor to the Bovine Serum Albumin Sensor (P)

An Investigational Blood Glucose Monitoring System Clinical Accuracy, Labeling Comprehension, and Human Factors Study

A Phase IIIB, Non-Randomized, Open-Label, Multi-Country, Multi-Centric Cross-Vaccination Study to Evaluate the Safety of An Investigational Vaccine for Herpes Zoster When Administered Intramuscularly on a Two-Dose Schedule to Subjects Who Previously Received Placebo in the Base Study

A Randomized, 30 Week, Active-Controlled, Open-Label, 3-Treatment Arm, Parallel-Group Multicenter Study Comparing the Efficacy and Safety of An Investigational Insulin Fixed Ratio Combination to Insulin Glargine Alone and to An Approved Diabetes Medication Alone on Top of Metformin in Patients with Type 2 Diabetes Mellitus. (T2DM).

A Randomized, Double-Blind Trial Comparing the Effect of An Approved Diabetes Medication with Placebo On Glycemic Control in Patients with Type 2 Diabetes on Basal Insulin Glargine.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of An Investigational Medication Given as Monotherapy to Adults with Type 2 Diabetes Mellitus.

An Approved Medication Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.

An Approved Medication + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects With Type 2 Diabetes Mellitus

A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of An Investigational Medication in Subjects with Type 2 Diabetes.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 26-Week Multicenter Study With a 78-Week Extension to Evaluate the Efficacy and Safety of An Approved Oral Diabetes Medication in Subjects with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Monotherapy.

Six-Month, Randomized, Open-label, Parallel-Group Comparison of An Investigational Insulin Analog to Humalog in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine.

Effect of An Approved Oral Diabetes Medication On 24-Hour Blood Glucose in Type 2 Diabetes Mellitus Patients Inadequately Controlled With Either Metformin Or Insulin.